Open AccessCoagulopathy and Thromboembolism in Covid-19- A Review
Author(s) -
Filipa Ribeiro Lucas
Publication year - 2022
Publication title -
journal of pulmonology research and reports
Language(s) - English
Resource type - Journals
ISSN - 2754-4761
DOI - 10.47363/jprr/2022(4)123
Subject(s) - coagulopathy , medicine , subclinical infection , intensive care medicine , pandemic , pneumonia , covid-19 , coronavirus , disease , hemostasis , systemic inflammation , severity of illness , inflammation , infectious disease (medical specialty) , immunology
The emergence of the novel coronavirus, SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) has resulted in a major global pandemic posing various challenges to the worldwide health care systems. Clinical course of the infection, known as coronavirus disease of 2019 (COVID-19, ranges from mild subclinical disease to a life-threatening systemic illness. Common symptoms include a flu-like illness with fever and inflammation, and in severe cases pneumonia and systemic inflammation that results in morbidity and mortality. One of the complications of COVID-19 is its disruption of normal hemostasis resulting coagulopathy and thromboembolism. In this following review, we discuss present knowledge; summarize existing published information on the underlying mechanisms of action for COVID-19-associated coagulopathy; and propose algorithms for screening, management, and prevention of COVID-19 patients.